Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Farmakis

Showing results (171-180 of 297) with videos related to

Pageof 30
Sort By:
European Journal of Heart Failure|March 10, 2025
Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysisPaschalis Karakasis, Eleftheria Lefkou, Konstantinos Pamporis, et al.
Heart Failure Reviews|May 30, 2020
The management of atrial fibrillation in heart failure: an expert panel consensusDimitrios Farmakis, Christina Chrysohoou, Gregory Giamouzis, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 19, 2017
Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failureVasiliki Bistola, Panagiotis Simitsis, Dimitrios Farmakis, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 25, 2005
Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancerDimitrios Pectasides, Dimitrios Farmakis, Maria Nikolaou, et al.
The American Journal of Cardiology|August 2, 2005
Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failureJohn T Parissis, Fotios Panou, Dimitrios Farmakis, et al.
Anticancer Research|December 12, 2003
Irinotecan and gemcitabine in patients with advanced non-small cell lung cancer, previously treated with cisplatin-based chemotherapy. A phase II studyDimitrios Pectasides, Nikolaos Mylonakis, Dimitrios Farmakis, et al.
International Journal of Cardiology|December 2, 2014
Determinants of the direct cost of heart failure hospitalization in a public tertiary hospitalJohn Parissis, Kostas Athanasakis, Dimitrios Farmakis, et al.
Anticancer Research|May 4, 2005
Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acidDimitrios Pectasides, Maria Nikolaou, Dimitrios Farmakis, et al.
The American Journal of Cardiology|December 23, 2008
Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathyJohn T Parissis, Maria Nikolaou, Dionysia Birmpa, et al.
Anticancer Research|August 17, 2005
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literatureDimitrios Pectasides, Gerasimos Aravantinos, George Fountzilas, et al.
Pageof 30

Showing results (171-180 of 297) with videos related to

Sort By:
Pageof 30
European Journal of Heart Failure|March 10, 2025
Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysisPaschalis Karakasis, Eleftheria Lefkou, Konstantinos Pamporis, et al.
Heart Failure Reviews|May 30, 2020
The management of atrial fibrillation in heart failure: an expert panel consensusDimitrios Farmakis, Christina Chrysohoou, Gregory Giamouzis, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 19, 2017
Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failureVasiliki Bistola, Panagiotis Simitsis, Dimitrios Farmakis, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 25, 2005
Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancerDimitrios Pectasides, Dimitrios Farmakis, Maria Nikolaou, et al.
The American Journal of Cardiology|August 2, 2005
Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failureJohn T Parissis, Fotios Panou, Dimitrios Farmakis, et al.
Anticancer Research|December 12, 2003
Irinotecan and gemcitabine in patients with advanced non-small cell lung cancer, previously treated with cisplatin-based chemotherapy. A phase II studyDimitrios Pectasides, Nikolaos Mylonakis, Dimitrios Farmakis, et al.
International Journal of Cardiology|December 2, 2014
Determinants of the direct cost of heart failure hospitalization in a public tertiary hospitalJohn Parissis, Kostas Athanasakis, Dimitrios Farmakis, et al.
Anticancer Research|May 4, 2005
Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acidDimitrios Pectasides, Maria Nikolaou, Dimitrios Farmakis, et al.
The American Journal of Cardiology|December 23, 2008
Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathyJohn T Parissis, Maria Nikolaou, Dionysia Birmpa, et al.
Anticancer Research|August 17, 2005
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literatureDimitrios Pectasides, Gerasimos Aravantinos, George Fountzilas, et al.
Pageof 30